Latest news with #CarlPrice
Yahoo
11-05-2025
- Yahoo
Chicago man beat 62-year-old amputee with baseball bat on South Side, police say
The Brief 62-year-old Angelo Sutton remains hospitalized after the beating Carl Price, 27, was arrested minutes after the attack Police say a metal baseball bat was used in the assault CHICAGO - A 27-year-old man has been charged in connection with a violent beating that left a 62-year-old man hospitalized on Chicago's South Side last Friday. What we know The attack happened in the 7400 block of South Coles Avenue in the South Shore neighborhood, according to Chicago police. Police say Carl Price, a convicted felon from Chicago, allegedly beat Angelo Sutton with a metal Louisville Slugger baseball bat, striking him in the face, the back of the head, and across his body. Witnesses also told police that Price stomped on Sutton during the attack. Sutton, whose right arm is amputated, suffered blunt force injuries to his face and head, including multiple lacerations and fractures to his mouth and upper arm. He was taken to the University of Chicago Hospital, where he remains hospitalized. The baseball bat used in the attack was recovered from the scene. Police said Price was taken into custody minutes after the assault. He was transported to Trinity Hospital to be treated for a laceration to his forehead before being released. He was expected to appear in court on Sunday on two counts of aggravated battery. What we don't know It remains unclear what prompted the alleged assault.
CBS News
11-05-2025
- CBS News
Chicago man charged with beating 62-year-old on South Side
A Chicago man was charged with beating a 62-year-old man Friday in the South Shore neighborhood. Carl Price, 27, was arrested by Chicago police officers around 11:08 a.m. in the 7400 block of South Coles Avenue. He was charged with two felony counts of aggravated battery with use of a deadly weapon and causing great bodily harm. He was identified as the suspect who beat the victim with a blunt metal object in the 7400 block of South Coles Avenue five minutes prior. He is scheduled to appear at a detention hearing on Sunday. No additional information is available at this time.
Yahoo
01-05-2025
- Health
- Yahoo
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races
The test, run on Abbott's portable i-STAT® Alinity® hand-held instrument, uses whole blood to help evaluate patients 18 years of age and older with a suspected mild traumatic brain injury, or concussion, producing lab-quality results in 15 minutes The test will be used by healthcare professionals in the medical facilities at all MotoAmerica races in 2025 ABBOTT PARK, Ill., and IRVINE, Calif., May 1, 2025 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare company, and MotoAmerica, the premier motorcycle road racing series in North America, announced today that MotoAmerica is the first professional sports organization worldwide to use Abbott's groundbreaking blood test to help assess suspected concussions for riders in the on-site medical facilities at all races. Abbott's test, the i-STAT TBI test cartridge, is used to evaluate patients 18 years of age and older who present with suspected mild traumatic brain injury (mTBI). It provides results in 15 minutes and may be used up to 24 hours after injury to help determine the need for a CT scan of the head. In 2024, Abbott's i-STAT TBI test received clearance from the U.S. Food and Drug Administration (FDA) to be used with whole blood, allowing doctors to quickly assess patients with suspected mTBI on the handheld i-STAT Alinity analyzer at the patient's side. "This is the first ever objective test that physicians have had at the point-of-care to assist in the assessment of concussions – it changes the game," said Carl Price, M.D., chief medical officer for MotoAmerica. "If a crash or fall does happen, the ability to quickly and objectively determine whether or not a rider needs a CT scan or additional evaluation, right there on-site, provides us—and our riders—with peace of mind." The i-STAT TBI test cartridge will be available in on-site medical facilities for all MotoAmerica races across the U.S. during the 2025 season, beginning with the race at Michelin Raceway Road in Atlanta, Ga. (May 2-4). "As both a neurologist and licensed physician, I know firsthand the limitations of relying on a subjective tool like the Glasgow Coma Scale in the assessment of brain injury," said Beth McQuiston, M.D., medical director in Abbott's diagnostics business. "The ability to objectively assess the need for a head CT scan following potential brain injury right at the point of care, whether that be at a hospital bedside or an on-site medical facility at a sporting event, means quick assessment and a quick path to the right treatment." At MotoAmerica, riders wear comprehensive protection, including airbag-equipped suits that inflate on impact, helmets tested for multiple impact forces, and full-body armor. The tracks also feature air fence barriers and a dedicated medical safety car. In the event of a crash or fall, immediate on-site assessment adds an extra layer of safety to determine if a rider requires a CT scan or further evaluation. "The standard of competition and performance in MotoAmerica continues to increase," said Chuck Aksland, chief operating officer, MotoAmerica. "Between the riders, the motorcycles, their gear, and now accessibility to the most innovative medical equipment, we continue to push our standards and practices to better protect our racers. Our use of Abbott's rapid blood test for concussion assessment furthers this commitment and will help us evaluate medical needs quickly and on location." According to the National Institutes of Health (NIH), traumatic brain injury from accidents or sports is a leading cause of death and disability in the United States. The Centers for Disease Control and Prevention (CDC) estimates 2.5 million people visit the emergency department for TBIs every year. How the test worksThe i-STAT TBI test cartridge with the i-STAT Alinity System requires a small venous blood sample – just a few drops applied to the test cartridge. The cartridge is then inserted into the portable i-STAT Alinity instrument. The test measures two brain-specific biomarkers that are released into the blood stream when there is a significant brain injury. If neither of these biomarkers measured are above an established cutoff, a significant injury has likely not occurred, and a CT scan can likely be avoided. Testing for these two biomarkers – ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) – following an injury can provide essential and objective information about a patient's condition and can help healthcare providers decide an appropriate treatment plan. The test was developed by Abbott, with support from the U.S. Army Medical Research and Development Command's (USAMRDC) U.S. Army Medical Materiel Development Activity (USAMMDA) and in collaboration with Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI). The ability to use whole blood to help assess patients with suspected mTBI is an important step in Abbott's vision to make its tests available in all settings where people seek care for head injuries. Today, the test is available to be used by hospitals, clinics, and any athletic organization with trained medical staff on-site and the ability to run moderately complex testing. Research and planning are ongoing to determine the feasibility of using these biomarkers similarly in teens and children. About MotoAmerica:MotoAmerica is officially sanctioned by the American Motorcyclist Association (AMA) and the Fédération Internationale de Motocyclisme (FIM), and it features nine classes of motorcycle road racing: Superbike, Supersport, King of the Baggers, Talent Cup, Super Hooligan, Stock 1000, Twins Cup, Build. Train. Race. and Mini Cup. About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. Connect with us at and on LinkedIn, Facebook, Instagram, X and Youtube. The i-STAT TBI test cartridge was developed with support by the U.S. Department of Defense U.S. Army Medical Research and Development Command's (USAMRDC) U.S. Army Medical Materiel Development Activity (USAMMDA). The USAMRDC has been dedicated to developing a solution for the objective detection and evaluation of TBI for more than two decades and has played a critical role in developing the TBI test on Abbott's i-STAT Alinity platform. (Reference to USAMRDC and USAMMDA does not imply or constitute endorsement by these organizations or by the Department of Defense or the U.S. Army.) The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) research team was the first to demonstrate how this TBI blood test can be used for the benefit of TBI patients in clinical care. View original content: SOURCE Abbott Sign in to access your portfolio
Yahoo
11-02-2025
- Yahoo
Deputies rescue sex trafficking victims in San Joaquin County
( — Two sex trafficking victims including a minor were rescued and three people were arrested during an operation in San Joaquin County. On Jan. 29, the San Joaquin County Sheriff's Office and local agencies carried out an operation they said focused on combating human trafficking and protecting vulnerable victims. According to SJSO, the operation included five traffic stops, resulting in a total of three arrests. More than 2,500 grams of fentanyl seized in Northern California traffic stop Among the arrestees were individuals facing a range of charges, including felony kidnapping, felony evading, felony robbery, and misdemeanor disorderly conduct related to prostitution. Notably, two victims were recovered during the operation—one adult and one juvenile, according to SJSO. 'A key moment of the operation involved the recovery of a 17-year-old juvenile victim, who had been missing from her placement in Southern California,' SJSO said on social media. 'The victim, who had been exploited as part of commercial sexual exploitation of children (CSEC), was spotted jumping from a moving vehicle at a truck stop near Charter Way and Navy Drive in Stockton around 9:50 p.m.' Woman pleads guilty as accessory in 2021 North Lake Tahoe murder case SJSO said law enforcement quickly responded with the help of an air unit that tracked the suspect vehicle. The pursuit lasted about nine miles and led to the arrest of Carl Price, 30, who now faces multiple charges, including felony kidnapping and felony evading. Both victims were interviewed during the operation, and victim services were offered. The juvenile victim reportedly accepted the services, ensuring her safety and providing support for her recovery. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Associated Press
30-01-2025
- Automotive
- Associated Press
Evolution Optiks Technology to Aid MotoAmerica in Concussion Diagnostics
CHRIST CHURCH, Barbados, Jan. 30, 2025 /PRNewswire/ -- Each time motorcycle racers go out on track, they are twisting the tiger's tail. They live for the thrill of speed and pushing themselves to the extreme. The danger is real and that's why motorcycle racing is one of the most exciting spectator sports. However, where there is risk, there is injury which makes rider safety a big topic in motorcycle racing. Since its inception in 2015, MotoAmerica, the premier US pro motorcycle road racing series, has been a forerunner in eliminating or reducing injury. Their riders are clad in some of the world's best safety gear and their bikes are equipped with a whole range of features designed to protect the racers. 'We care about the well-being of our riders and make every effort to keep them as safe as possible by providing the best available gear and equipment and using state-of-the-art technology in injury assessment', says MotoAmerica COO Chuck Aksland. Since one of the most common injuries in motorcycle racing is concussion/mTBI (mild traumatic brain injury), MotoAmerica introduced a concussion protocol early on and has continuously adopted novel and more advanced tools and screening systems as they became available. Renowned and multi-published Concussion and Vestibular Specialist Jim Buskirk, Assistant Professor at Chicago's Rosalind Franklin University, provides the medical expertise, in collaboration with MotoAmerica's Chief Medical Officer, Dr. Carl Price. Jim's primary research interest is the recovery of function following concussion/mTBI in sports and he works with various motorsports organizations, professional sports teams as well as amateur youth sports associations. He says: 'As a researcher, I am always on the lookout for new technologies to improve the assessment and treatment of mTBI. So when Dr. Steve Olvey, my co-consultant at IndyCar and Chief Medical Advisor for Evolution Optiks, introduced me to DeCon, my interest was piqued. I had the chance to use the device for testing and data collection and it has so much potential that this season, I'm planning on a full IRB study with DeCon for MotoAmerica.' Dr. Carl Price adds: 'We are fortunate to have an expert like Jim Buskirk on our team to help us manage concussion in our sport. The DeCon device, together with clinical findings, may become an integral part of our concussion management program. We are also excited to add new peripheral blood biomarkers to this mix and feel that the combination will advance the science, but more importantly, the care of our riders.' DeCon is the flagship product of the NeuroDynamiks ™ brand of Evolution Optiks - the leading name in light field technology solutions. The portable head-mounted device uses proprietary technology to track and analyze involuntary movements of the eye in response to visual stimuli and positional changes. DeCon can perform dozens of established and new neurological tests, the results of which are simultaneously recorded on the device and, if required, can be made available remotely for interpretation by a qualified medical practitioner. Its compact and relatively lightweight design makes it ideal for sideline use, allowing for rapid diagnosis and treatment decision-making. With added AI-based optimizations, the potential for the DeCon device expands tenfold into a broad space of medical conditions and performance training, by analyzing objective data collected from its onboard cameras and sensors and cross-checking against large data sets of previously diagnosed cases. AI-based analysis of individual patient factors, crash characteristics, and correlation with other diagnostic methodologies will enable personalized treatment plans, accurate predictions of recovery times, and early identification of potential complications.
